University of Colorado Denver CTO(CTRC) — Aurora, Colorado

University of Colorado Denver CTO(CTRC) is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Colorado Denver CTO(CTRC) has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Neoplasm, Advanced Cancers, BRAF V600E-mutant Metastatic Colorectal Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Aurora

Browse all research sites in Colorado · View every site in Aurora

• University of Colorado Anschutz Cancer Pavilion
• University of Colorado Anschutz Medical Campus University of Colorado Cancer Center
• University of Colorado Denver, Anschutz Medical Campus , Behavioral Health and Wellness Program
• Children's Hospital Colorado /ID# 137017
• University of Colorado (UC) Health Transplant Center - Anschutz
• Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology
• CU Anschutz / University of Colorado
• Colorado University Denver
• University of Colorado Univ.ofColoradoCancerCenter
• University of Colorado Hospital CTRC
• University of Colorado Denver; Department of Medicine; Anschutz Health and Wellness Center
• University of Colorado Cancer Centre

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Denver CTO(CTRC)?

University of Colorado Denver CTO(CTRC) has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Denver CTO(CTRC) conducted?

University of Colorado Denver CTO(CTRC) has 9 clinical trials on record, with 1 currently active. Their work covers Neoplasm, Advanced Cancers, BRAF V600E-mutant Metastatic Colorectal Cancer.

Is University of Colorado Denver CTO(CTRC) accredited by Crixeo Clinical Trials?

University of Colorado Denver CTO(CTRC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Denver CTO(CTRC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.